INDEX VALUES   |

Home > Our Indexes > LSCIBC

Download Methodology

LifeSci Biotechnology Clinical Trials Index


The LifeSci Biotechnology Clinical Trials Index ("LSCIBC") is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development. The inception date for LSCIBC was November 3, 2014.

LSCIBCS&P 500
Prior Day Closing Value4498.754771.02
Prior Day Change %-0.39%-0.59%
Current Value
Current Day Change %-0.72%+1.51%
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume

Index Characteristics (Oct 19, 2017)


No. of Constituents 73
Total Market Cap ($ in millions) 0
Mean Market Cap ($ in millions) 0
Median Market Cap ($ in millions) 0
Largest Constituent ($ in millions) 0
Smallest Constituent ($ in millions) 0

Market Cap Breakdown (Oct 19, 2017)


Top 10 Constituents (Oct 19, 2017)


Constituent Ticker Weight
Anaptysbio Inc ANAB 3.15%
Myokardia Inc MYOK 2.95%
Dynavax Technologies Corp DVAX 2.90%
Beigene Ltd-adr BGNE 2.32%
Arena Pharmaceuticals Inc ARNA 2.21%
Ignyta Inc RXDX 2.11%
Juno Therapeutics Inc JUNO 2.05%
Sangamo Therapeutics Inc SGMO 2.03%
Fibrogen Inc FGEN 2.02%
Insmed Inc INSM 1.86%
Data Updated Daily
Download All Constituents